After 10 Years, US FDA ‘Additional Conditions’ Proposed Rule Offers ‘Novel Switch’ Pathway

 
• By Hannah Daniel

Publication of "ACNU" proposed rule wasn’t reached in a straight line and featured coining another term with a more of a regulatory sound, “NSURE.” The proposed rule also detours on explaining where the agency wouldn’t steer OTC drug manufacturing and marketing.

The new proposed rule was not developed in a straight line over the last several years. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards